The University of Minnesota Otitis Media Research Center, formed in 1978, comprises a multidisciplinary research team in the clinical fields of otolaryngology, pediatrics, audiology, and infectious disease as well as the basic science fields of histopathology, epidemiology, microbiology, immunology, biostatistics, pharmacology, physiology, and biochemistry. The team has focused on studies designed to elucidate the pathophysiology of the otitis media continuum, and considerable progress has been made in describing this continuum by using the basic science approaches available in the Center. The collaboration of basic and clinical scientists has created a synergy of goals, ideas, and methods leading to new hypotheses and progress, ultimately resulting in improved patient care methods.
JuhnSKHamaguchiYJungTTK. Biochemistry of middle ear effusion. In: BernsteinJOgraP, eds. Immunology of the ear. New York, NY: Raven Press, 1987: 319–29.
11.
JuhnSKJungTTKGiebinkGSEdlinJ. Factors involved in the alteration of middle ear effusion composition. In: LimDJ, ed. Recent advances in otitis media with effusion. Philadelphia, Pa: BC Decker, 1984: 192–5.
12.
HaradaTJuhnSKGiebinkGS. Biochemical parameters reflecting the vascular permeability and inflammatory stage in otitis media. Otolaryngol Head Neck Surg1988; 99: 160.
13.
SakagamiMHaradaTJuhnSKDuvallAJIII. Morphologic and biochemical study of vascular permeability of the middle ear mucosa in experimental otitis media. Ann Otol Rhinol Laryngol1990 (in press).
14.
AgarwalSPEdlinJJuhnSKGiebinkGS. Effects of ampicillin treatment on the biochemical and cytological profiles of experimental purulent otitis media. In: LimDJBluestoneCDKleinJONelsonJD, eds. Recent advances in otitis media. Toronto, Canada: BC Decker, 1988: 228–31.
15.
JuhnSKHamaguchiYMorizonoT. Relationship between middle ear inflammation and round window membrane permeability in antigen-induced otitis media. In: LimDJBluestoneCDKleinJONelsonJD, eds. Recent advances in otitis media. Toronto, Canada: BC Decker, 1988: 425–8.
16.
JuhnSK. Barrier systems in the inner ear. Acta Otolaryngol [Suppl] (Stockh) 1988(suppl 458): 79–83.
17.
GiebinkGSPayneEEMillsELJuhnSKQuiePG. Experimental otitis media due to Streptococcus pneumoniae: Immunopathogenic response in the chinchilla. J Infect Dis1976; 134: 595–604.
18.
GiebinkGSBerzinsIKMarkerSCSchiffmanG. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun1980; 30: 445–50.
19.
GiebinkGSRipleyMLSheaDAWrightPFPaparellaMM. Clinical-histopathological correlations in experimental otitis media: Implications for silent otitis media in humans. Pediatr Res1985; 19: 389–97.
20.
GiebinkGSCarlsonBAHetheringtonSVHostetterMKLeCTJuhnSK. Bacterial and polymorphonuclear leukocyte contribution to middle ear inflammation in chronic otitis media with effusion. Ann Otol Rhinol Laryngol1985; 94: 398–402.
21.
GiebinkGSJuhnSKWeberMLLeCT. The bacteriology and cytology of chronic otitis media with effusion. Pediatr Infect Dis1982; 1: 98–103.
22.
GiebinkGSLeCTPaparellaMM. Epidemiology of otitis media with effusion in children. Arch Otolaryngol1982; 108: 563–6.
23.
DalyKGiebinkGSLeCT. Risk determination for chronic otitis media with effusion. Pediatr Infect Dis1988; 7: 471–5.
24.
Ripley-PetzoldtMLGiebinkGSJuhnSKAeppliDTomaszATuomanenE. The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis1988; 157: 245–55.
25.
GiebinkGSSchiffmanG. Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.Infect Immun1983; 39: 638–44.
26.
GiebinkGSBerzinsIKSchiffmanGQuiePG. Experimental otitis media following nasal colonization with type 7F Streptococcus pneumoniae: Prevention after vaccination with pneumococcal capsular polysaccharide. J Infect Dis1979; 140: 716–23.
27.
ShurinPAGiebinkGSWegmanDL. Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin. J Clin Microbiol1988; 26: 755–9.
28.
MorizonoTJohnstoneBMEntjepH. The ototoxicity of antiseptics (preliminary report). J Otolaryngol Soc Aust1973; 3: 550–3.
29.
MorizonoTJohnstoneBM. Ototoxicity of chloramphenicol eardrops with propylene glycol as solvent. Med J Aust1975; 2: 634–8.
30.
MorizonoTPaparellaMMJuhnSK. Ototoxicity of propylene glycol in experimental animals. Am J Otol1980; 1: 393–9.
31.
MorizonoTSikoraM. Ototoxicity of ethanol in the tympanic cleft in animals. Acta Otolaryngol (Stockh)1981; 92: 33–40.
32.
MorizonoTSikoraJ. Ototoxicity of povidone-iodine (Betadine) applied in the tympanic cleft in chinchillas. Arch Otolaryngol1982; 108: 210–3.
33.
MeyerhoffWLMorizonoTWrightCGShaddockLCSheaDSikoraMA. Tympanostomy tubes and otic drops. Laryngoscope1983; 93: 1022–7.
34.
MorizonoTGiebinkGSSikoraMAPaparellaMM. Sensorineural hearing loss in an animal model of purulent otitis media. In: LimDJBluestoneCDKleinJONelsonJD, eds. Recent advances in otitis media. Toronto, Canada: BC Decker, 1988: 341–4.
35.
IkedaKMorizonoT. The changes of the round window membrane permeability in otitis media. Arch Otolaryngol Head Neck Surg1988; 114: 895–7.
36.
GoycooleaMVPaparellaMMCarpenterA-MJuhnSK. Oval and round window changes in otitis media: An experimental study in the cat. Surg Forum1978; 29: 578–80.
37.
GoycooleaMVPaparellaMMCarpenterA-MJuhnSK. A longitudinal study of cellular changes in experimental otitis media. Otolaryngol Head Neck Surg1979; 87: 685–700.
38.
GoycooleaMVPaparellaMMGoldbergGCarpenterA-M. Permeability of the round window membrane in otitis media. Arch Otolaryngol1980; 106: 430–3.
39.
GoycooleaMVPaparellaMMJuhnSKCarpenterA-M. Cells involved in the middle ear defense system. Ann Otol Rhinol Laryngol1980; 89(suppl 68): 121–8.
40.
GoycooleaMVPaparellaMMCarpenterA-M. Infiltration of the tensor tympani muscle and stapedius muscles in otitis media. An experimental study in the cat. Int J Pediatr Otorhinolaryngol1979; 1: 231–9.
41.
GoycooleaMVPaparellaMMGoldbergBSchlievertPMCarpenterA-M. Permeability of the middle ear to staphylococcal pyrogenic exotoxin in otitis media. Int J Pediatr Otorhinolaryngol1980; 1: 301–8.
42.
GoycooleaMVCarpenterA-MPaparellaMMJuhnSK. Ganglia and ganglion cells in the middle ear of the cat: Preliminary report. Arch Otolaryngol1980; 106: 269–71.
43.
GoycooleaMVPaparellaMMCarpenterA-M. Oval and round window changes in otitis media: Potential pathways between middle and inner ear. Laryngoscope1980; 90: 1387–91.
44.
GoldbergBGoycooleaMVSchlievertPM. Passage of albumin from middle ear to inner ear in otitis media: An experimental study in the chinchilla. Am J Otol1981; 2: 210–4.
45.
GoycooleaMVMuchowDSchachernP. Experimental studies on round window membrane structure, function, and permeability. Laryngoscope1988; 98(suppl 44).
46.
LeCT. A symmetric bivariate binomial distribution and its applications to the analysis of clustered samples in medical research. Biom J1984; 26: 289–94.
47.
LeCT. Analysis of nested designs with binomially-distributed outcome variables. Biom J1987; 29: 153–61.
48.
LeCT. Testing for linear trends using correlated otolaryngology or ophthalmology data. Biometrics1988; 44: 299–303.
49.
ErdmannGRCanafaxDMGiebinkGS. High-performance liquid chromatographic analysis of trimethoprim and sulfamethoxazole in microliter volumes of chinchilla middle ear effusion and serum. J Chromatogr1988; 433: 187–95.
50.
CanafaxDMGiebinkGSErdmannGRCipolleRJJuhnSK. Penetration of trimethoprim and sulfamethoxazole into the middle ear in experimental otitis media. In: LimDJBluestoneCDKleinJONelsonJD, eds. Recent advances in otitis media. Toronto, Canada: BC Decker, 1988: 219–22.
51.
CanafaxDMNonomuraNErdmannGRLeCTJuhnSKGiebinkGS. Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharm Res1989; 6: 279–85.
52.
GiebinkGSCanafaxDM. Controversies in the management of acute otitis media. In: AronoffSCHughesWTKohlSSpeckWTWaldER, eds. Advances in pediatric infectious diseases. Vol 3. Chicago, Ill: Year Book Medical Publishers, 1988: 47–63.
